Your response should be formatted as Markdown paragraphs
Write a critical and concise analysis of this human protein system, describing your reasoning as you go and providing references to scientific papers.

A critical goal of the analysis is to determine if this is a novel complex or if any proteins are novel members of a known complex

Format with Title, Summary, and References sections.        
Avoid overly general statements of how the proteins are involved in various cellular processes        
Avoid repeating the goals of the analysis.

What cellular components and complexes are involved in this system?
What mechanisms and biological processes are performed by this system?
Propose a name for the system to reflect the cellular location and function, and should be specific but brief. Do not compose an acronym. Place it as the title of your report
Human Proteins: CCDC138, CCNC, CDK19, CDK8, ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9, PDZK1.

System features from GO terms: 
protein binding: 22 proteins: CCNC, CDK8, ILK, MED1, MED12, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9, PDZK1
nucleus: 22 proteins: CCNC, CDK19, CDK8, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9
mediator complex: 22 proteins: CCNC, CDK19, CDK8, MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9
nucleoplasm: 19 proteins: CCNC, CDK19, CDK8, ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6
 transcription initiation by RNA polymerase II: 19 proteins: MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9
 transcription elongation by RNA polymerase II: 17 proteins: MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9
RNA polymerase II preinitiation complex assembly: 17 proteins: MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9
core mediator complex: 17 proteins: MED1, MED14, MED15, MED17, MED18, MED21, MED22, MED23, MED25, MED27, MED28, MED29, MED30, MED31, MED4, MED6, MED9
 transcription by RNA polymerase II: 16 proteins: CCNC, CDK8, MED1, MED12, MED13, MED14, MED17, MED18, MED21, MED23, MED25, MED27, MED29, MED31, MED4, MED6
transcription coregulator activity: 14 proteins: MED1, MED12, MED13, MED14, MED15, MED17, MED18, MED21, MED22, MED29, MED30, MED31, MED4, MED9
transcription coactivator activity: 11 proteins: MED1, MED12, MED13, MED14, MED17, MED21, MED23, MED27, MED30, MED4, MED6
membrane: 10 proteins: ILK, MED1, MED12, MED13, MED14, MED15, MED17, MED28, MED4, MED6
 DNA-templated transcription: 9 proteins: ILK, MED1, MED12, MED13, MED14, MED17, MED23, MED30, MED4
somatic stem cell population maintenance: 9 proteins: MED12, MED14, MED15, MED17, MED21, MED27, MED28, MED30, MED6
nuclear receptor coactivator activity: 7 proteins: MED1, MED12, MED13, MED14, MED17, MED30, MED4
nuclear vitamin D receptor binding: 7 proteins: MED1, MED12, MED13, MED14, MED17, MED30, MED4
nuclear thyroid hormone receptor binding: 6 proteins: MED1, MED12, MED13, MED17, MED30, MED4
ubiquitin protein ligase activity: 5 proteins: MED12, MED17, MED27, MED30, MED31
protein ubiquitination: 5 proteins: MED12, MED17, MED27, MED30, MED31
ubiquitin ligase complex: 5 proteins: MED12, MED17, MED27, MED30, MED31
transcription regulator complex: 4 proteins: MED17, MED23, MED25, MED27
ATP binding: 3 proteins: CDK19, CDK8, ILK
protein serine kinase activity: 3 proteins: CDK19, CDK8, ILK
protein phosphorylation: 3 proteins: CDK19, CDK8, ILK
cytosol: 3 proteins: CDK19, ILK, MED27
nucleolus: 3 proteins: CDK8, MED1, MED27
transcription coactivator binding: 3 proteins: MED1, MED25, MED6
transcription initiation at RNA polymerase II promoter: 3 proteins: MED17, MED23, MED27
G0 to G1 transition: 2 proteins: CCNC, MED1
cyclin-dependent protein serine/threonine kinase activity: 2 proteins: CDK19, CDK8
 cell cycle: 2 proteins: CDK19, CDK8
cell morphogenesis: 2 proteins: ILK, MED1
plasma membrane: 2 proteins: ILK, PDZK1
DNA binding: 2 proteins: MED1, MED6
chromatin binding: 2 proteins: MED1, MED12
nuclear retinoic acid receptor binding: 2 proteins: MED1, MED25
protein-containing complex binding: 2 proteins: MED1, PDZK1
negative regulation of transcription by RNA polymerase II: 2 proteins: MED1, MED25
 gene expression: 2 proteins: MED1, MED23
transcription factor binding: 2 proteins: MED12, MED29
DNA-templated transcription: 2 proteins: MED12, MED13
cytoplasm: 2 proteins: MED15, MED22
negative regulation of fibroblast proliferation: 2 proteins: MED25, MED31
